Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST) Registry.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
01 2022
Historique:
received: 17 06 2021
revised: 09 07 2021
accepted: 13 07 2021
pubmed: 3 8 2021
medline: 12 3 2022
entrez: 2 8 2021
Statut: ppublish

Résumé

Medical treatment of inappropriate sinus tachycardia (IST) remains suboptimal. Radiofrequency sinus node (RF-SN) ablation has poor success and higher complication rates. We aimed to compare clinical outcomes of the novel SN sparing hybrid ablation technique with those of RF-SN modification for IST management. This is a multicenter prospective registry comparing the SN sparing hybrid ablation strategy with RF-SN modification. The hybrid procedure was performed using an RF bipolar clamp, isolating superior vena cava/inferior vena cava with the creation of a lateral line across the crista terminalis while sparing the SN region (identified by endocardial 3-dimensional mapping). RF-SN modification was performed by endocardial and/or epicardial mapping and ablation at the site of earliest atrial activation. Of the 100 patients (hybrid ablation group, n = 50; RF-SN group, n = 50), 82% were women, and the mean age was 22.8 years. Normal sinus rhythm and rate were restored in all patients in the hybrid group (vs 84% in the RF-SN group; P = .006). Hybrid ablation was associated with significantly better improvement in mean daily heart rate and peak 6-minute walk heart rate compared with RF-SN ablation. The RF-SN group had a significantly higher rate of redo procedures (100% vs 8%; P < .001), phrenic nerve injury (14% vs 0%; P = .012), lower acute pericarditis (48% vs 92%; P < .0001), permanent pacemaker implantation (50% vs 4%; P < .0001) than did the hybrid ablation group. The novel sinus node sparing hybrid ablation procedure appears to be more efficacious and safer in patients with symptomatic drug-resistant IST with long-term durability than RF-SN ablation.

Sections du résumé

BACKGROUND
Medical treatment of inappropriate sinus tachycardia (IST) remains suboptimal. Radiofrequency sinus node (RF-SN) ablation has poor success and higher complication rates.
OBJECTIVE
We aimed to compare clinical outcomes of the novel SN sparing hybrid ablation technique with those of RF-SN modification for IST management.
METHODS
This is a multicenter prospective registry comparing the SN sparing hybrid ablation strategy with RF-SN modification. The hybrid procedure was performed using an RF bipolar clamp, isolating superior vena cava/inferior vena cava with the creation of a lateral line across the crista terminalis while sparing the SN region (identified by endocardial 3-dimensional mapping). RF-SN modification was performed by endocardial and/or epicardial mapping and ablation at the site of earliest atrial activation.
RESULTS
Of the 100 patients (hybrid ablation group, n = 50; RF-SN group, n = 50), 82% were women, and the mean age was 22.8 years. Normal sinus rhythm and rate were restored in all patients in the hybrid group (vs 84% in the RF-SN group; P = .006). Hybrid ablation was associated with significantly better improvement in mean daily heart rate and peak 6-minute walk heart rate compared with RF-SN ablation. The RF-SN group had a significantly higher rate of redo procedures (100% vs 8%; P < .001), phrenic nerve injury (14% vs 0%; P = .012), lower acute pericarditis (48% vs 92%; P < .0001), permanent pacemaker implantation (50% vs 4%; P < .0001) than did the hybrid ablation group.
CONCLUSION
The novel sinus node sparing hybrid ablation procedure appears to be more efficacious and safer in patients with symptomatic drug-resistant IST with long-term durability than RF-SN ablation.

Identifiants

pubmed: 34339847
pii: S1547-5271(21)01877-4
doi: 10.1016/j.hrthm.2021.07.010
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-38

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Dhanunjaya Lakkireddy (D)

Kansas City Heart Rhythm Institute, Overland Park, Kansas. Electronic address: dhanunjaya.lakkireddy@hcahealthcare.com.

Jalaj Garg (J)

Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California.

Carlo DeAsmundis (C)

Heart Rhythm Management Center, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, Brussels, Belgium.

Mark LaMeier (M)

Cardiac Surgery Department, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, Brussels, Belgium.

Ahmed Romeya (A)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Justin Vanmeetren (J)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Peter Park (P)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Rangarao Tummala (R)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Scott Koerber (S)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Chandra Vasamreddy (C)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Alap Shah (A)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Poojita Shivamurthy (P)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Ken Frazier (K)

AtriCure, Inc., Cincinnati, Ohio.

Yashi Awasthi (Y)

AtriCure, Inc., Cincinnati, Ohio.

Gian Battista Chierchia (GB)

Heart Rhythm Management Center, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, Brussels, Belgium.

Donita Atkins (D)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Sudha Bommana (S)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Luigi Di Biase (L)

Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

Amin Al-Ahmad (A)

Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.

Andrea Natale (A)

Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.

Rakesh Gopinathannair (R)

Kansas City Heart Rhythm Institute, Overland Park, Kansas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH